NCT02105636 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 240
- group Id
- BG001
- value
- 121
- group Id
- BG002
- value
- 361
- units
- Participants
- groups
- description
- Nivolumab was provided at a dose of 3 milligrams/kilogram (mg/kg) using an intravenous (IV) solution for Injection every 2 weeks until disease progression.
- id
- BG000
- title
- Nivolumab 3mg/kg
- description
- Participants were provided a dose of Cetuximab intravenous (IV) solution for injection at a dose of 400 milligrams per square meter (mg/m\^2) for the first dose followed that a doses of 250 mg/m\^2 weekly until disease progression OR a Methotrexate intravenous (IV) solution for Injection at a dose of 40 or 60 mg/m\^2 weekly until disease progression OR a Docetaxel intravenous (IV) solution for Injection at a dose of 30 or 40 mg/m\^2 weekly until disease progression. The decision regarding which treatment the participant received was at the discretion of the investigator and referred to as Investigators Choice
- id
- BG001
- title
- Investigators Choice
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.15
- value
- 59.0
- group Id
- BG001
- spread
- 11.00
- value
- 59.4
- group Id
- BG002
- spread
- 10.43
- value
- 59.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 172
- group Id
- BG001
- value
- 76
- group Id
- BG002
- value
- 248
- title
- < 65 years
- categories
- measurements
- group Id
- BG000
- value
- 56
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 95
- title
- >=65 and <75 years
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 18
- title
- >=75 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 61
- title
- Female
- measurements
- group Id
- BG000
- value
- 197
- group Id
- BG001
- value
- 103
- group Id
- BG002
- value
- 300
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 196
- group Id
- BG001
- value
- 104
- group Id
- BG002
- value
- 300
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 13
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 29
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 43
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 5
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 13
- title
- Hispanic/Latino
- categories
- measurements
- group Id
- BG000
- value
- 132
- group Id
- BG001
- value
- 60
- group Id
- BG002
- value
- 192
- title
- Not Hispanic/Latino
- categories
- measurements
- group Id
- BG000
- value
- 99
- group Id
- BG001
- value
- 57
- group Id
- BG002
- value
- 156
- title
- Not Reported
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 240
- group Id
- BG001
- value
- 121
- group Id
- BG002
- value
- 361
- units
- Participants
- groups
- description
- Nivolumab was provided at a dose of 3 milligrams/kilogram (mg/kg) using an intravenous (IV) solution for Injection every 2 weeks until disease progression.
- id
- BG000
- title
- Nivolumab 3mg/kg
- description
- Participants were provided a dose of Cetuximab intravenous (IV) solution for injection at a dose of 400 milligrams per square meter (mg/m\^2) for the first dose followed that a doses of 250 mg/m\^2 weekly until disease progression OR a Methotrexate intravenous (IV) solution for Injection at a dose of 40 or 60 mg/m\^2 weekly until disease progression OR a Docetaxel intravenous (IV) solution for Injection at a dose of 30 or 40 mg/m\^2 weekly until disease progression. The decision regarding which treatment the participant received was at the discretion of the investigator and referred to as Investigators Choice
- id
- BG001
- title
- Investigators Choice
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.15
- value
- 59.0
- group Id
- BG001
- spread
- 11.00
- value
- 59.4
- group Id
- BG002
- spread
- 10.43
- value
- 59.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 172
- group Id
- BG001
- value
- 76
- group Id
- BG002
- value
- 248
- title
- < 65 years
- categories
- measurements
- group Id
- BG000
- value
- 56
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 95
- title
- >=65 and <75 years
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 18
- title
- >=75 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 61
- title
- Female
- measurements
- group Id
- BG000
- value
- 197
- group Id
- BG001
- value
- 103
- group Id
- BG002
- value
- 300
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 196
- group Id
- BG001
- value
- 104
- group Id
- BG002
- value
- 300
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 13
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 29
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 43
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 5
- title
- Other
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 13
- title
- Hispanic/Latino
- categories
- measurements
- group Id
- BG000
- value
- 132
- group Id
- BG001
- value
- 60
- group Id
- BG002
- value
- 192
- title
- Not Hispanic/Latino
- categories
- measurements
- group Id
- BG000
- value
- 99
- group Id
- BG001
- value
- 57
- group Id
- BG002
- value
- 156
- title
- Not Reported
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle